The FDA has granted Myoscience 510(k) clearance for its Iovera device, a nonopioid and nonsystemic treatment for providing relief of knee osteoarthritis-related pain and symptoms. The device delivers targeted cold therapy to temporarily block a peripheral nerve from sending pain signals.
Myoscience's knee osteoarthritis treatment device wins FDA clearance
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.